This paper discusses the relationship between medical innovations and ageing from a health economics perspective and surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health innovations. Particular focus is on the endogeneity of...

Fehlende Medikamente zur Bekämpfung armutsassoziierter Krankheiten sind ein globales Gesundheitsproblem.Katrin Gerlinger stellt in diesem Band Initiativen öffentlicher, gemeinnütziger und privater Akteure zur Stärkung der Produktentwicklung vor und nennt politische Optionen zur Förderung...

Introduction -- New Tools for Distribution Management in Health Industry -- An Assessment of The Financial Performance Of The Hospital Services Sub-Sector In Turkey By Ratio Analysis Method.-Pharmaceutical Warehousing 4.0 in Healthcare Supply Chain -- Internet of Things and its Applications in...